{"version":"1.0","type":"link","title":"Ultralow Prostate-specific Antigen Nadir After Apalutamide: Outcomes in Synchronous Versus Metachronous Metastatic Hormone-sensitive Prostate Cancer.","author_name":"Wenzel M 외","author_url":"https://prs-insight.online/author/Wenzel%20M","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/137754","thumbnail_width":1200,"thumbnail_height":630}